M7445
MNS
≥98% (HPLC), solid
Synonym(s):
3,4-Methylenedioxy-beta-nitrostyrene
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C9H7NO4
CAS Number:
Molecular Weight:
193.16
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
assay
≥98% (HPLC)
form
solid
color
yellow to green
solubility
H2O: <2 mg/mL, DMSO: ≥5 mg/mL
SMILES string
[O-][N+](=O)\C=C\c1ccc2OCOc2c1
InChI
1S/C9H7NO4/c11-10(12)4-3-7-1-2-8-9(5-7)14-6-13-8/h1-5H,6H2/b4-3+
InChI key
KFLWBZPSJQPRDD-ONEGZZNKSA-N
Biochem/physiol Actions
Src and Syk kinase inhibitor that prevents phosphorylation and cytoskeletal association of GPIIb/IIIa and talin.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
Storage Class
11 - Combustible Solids
wgk
WGK 3
ppe
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Felix P Phiri et al.
Scientific reports, 9(1), 6566-6566 (2019-04-27)
Selenium (Se) is an essential human micronutrient. Deficiency of Se decreases the activity of selenoproteins and can compromise immune and thyroid function and cognitive development, and increase risks from non-communicable diseases. The prevalence of Se deficiency is unknown in many
Matthew S Karafin et al.
Transfusion, 55(6 Pt 2), 1399-1406 (2015-03-12)
Much effort and resources have been devoted to programs that provide transfusion support for patients with sickle cell disease (SCD). The focus of many donor programs is to prevent alloimmunization by recruiting racially matched African American donors to limit the
Jay E Birnbaum et al.
Journal of cosmetic dermatology, 16(1), 120-131 (2016-10-27)
Dietary or supplementary intake of nutrients and other ingredients positively affects skin appearance. Evaluate a multicomponent nutritional supplement on photoaged skin. This multicenter, double-blind, placebo-controlled trial randomized healthy 35- to 65-year-old women with Fitzpatrick skin types I-IV and Glogau classification